<DOC>
	<DOC>NCT00326183</DOC>
	<brief_summary>Two doses each of Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella [Oka/Merck] Virus Vaccine Live will be given concomitantly or non-concomitantly. Safety data will be collected following each vaccination.</brief_summary>
	<brief_title>Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<criteria>Negative clinical history of hepatitis A, measles, mumps, rubella, varicella (chickenpox), and/or zoster No other vaccinations scheduled to be administered at the time of the first or second doses of VAQTA(TM) and ProQuad(TM) Previously vaccinated with any hepatitis A vaccine, measles, mumps, rubella, and/or varicella vaccine either alone or in any combination History of allergy to any vaccine component History of seizure disorder Immunosuppressed including congenial and acquired conditions and immunosuppressive therapy Known severe thrombocytopenia or any other coagulation disorder that would contraindicate intramuscular injections Recent (&lt;72 hours) febrile illness (&gt;100.3 degrees F [&gt;37.9 degrees C] oral equivalent) prior to study vaccination.</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>17 Months</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>